Cooper Companies (NASDAQ:COO – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...